Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

XLV vs RSPH overlap: 19% of top holdings shared

Bottom line

How much do XLV and RSPH overlap?

19% of their top holdings overlap by weight. 7 securities appear in both funds' top 25, making up 21.2% of XLV's assets and 12.7% of RSPH's. They are substantially different portfolios, so owning both adds real diversification.

Updated Nov 22, 2026

Overlap at a glance

XLVRSPH
Weight overlap (top 25)19%
Shared holdings7
Weight in shared holdings21.2%12.7%
Total positions6563
Expense ratio0.08%0.4%
Holdings as ofJun 30, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Holdings XLV and RSPH have in common

Holding% of XLV% of RSPHOverlap
AbbVie Inc7.74%1.73%1.73%
Amgen Inc3.40%1.77%1.77%
Thermo Fisher Scientific Inc3.24%1.84%1.84%
Abbott Laboratories2.75%1.83%1.83%
Bristol-Myers Squibb Co2.05%1.82%1.82%
Regeneron Pharmaceuticals Inc1.08%1.96%1.08%
Cencora Inc0.96%1.71%0.96%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in XLV

  1. Eli Lilly & Co — 16.51%
  2. Johnson & Johnson — 10.64%
  3. UnitedHealth Group Inc — 6.57%
  4. Merck & Co Inc — 5.52%
  5. Gilead Sciences Inc — 2.73%
  6. Intuitive Surgical Inc — 2.45%
  7. Pfizer Inc — 2.39%
  8. CVS Health Corp — 2.30%
  9. Vertex Pharmaceuticals Inc — 2.19%
  10. Danaher Corp — 2.09%
  11. Stryker Corp — 1.89%
  12. Medtronic PLC — 1.75%
  13. McKesson Corp — 1.58%
  14. Elevance Health Inc — 1.46%
  15. Cigna Group/The — 1.27%

Only in RSPH

  1. Bio-Techne Corp. — 2.13%
  2. IQVIA Holdings Inc. — 2.00%
  3. Baxter International Inc. — 1.99%
  4. Mettler-Toledo International Inc. — 1.94%
  5. Charles River Laboratories International, Inc. — 1.93%
  6. Veeva Systems Inc. — 1.93%
  7. DaVita Inc. — 1.87%
  8. Moderna, Inc. — 1.85%
  9. Universal Health Services, Inc. — 1.80%
  10. Labcorp Holdings Inc. — 1.78%
  11. Quest Diagnostics Inc. — 1.77%
  12. Incyte Corp. — 1.76%
  13. Becton, Dickinson and Co. — 1.73%
  14. DexCom, Inc. — 1.73%
  15. Viatris Inc. — 1.72%

Asset mix

Asset typeXLVRSPH
Stocks99.7%99.9%
Cash & short-term funds0.3%2.3%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Country mix

CountryXLVRSPH
US97.9%98.9%
IE2.1%3.4%

Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do XLV and RSPH overlap?
About 19% by weight. 7 securities appear in both funds' top 25 holdings; they make up 21.2% of XLV's assets and 12.7% of RSPH's. They are substantially different portfolios, so owning both adds real diversification.
What stocks do XLV and RSPH have in common?
The largest shared holdings are Thermo Fisher Scientific Inc, Abbott Laboratories, Bristol-Myers Squibb Co, Amgen Inc, AbbVie Inc.
Should I own both XLV and RSPH?
Their portfolios are mostly different, so owning both can add diversification. Check how each fits your overall allocation.
Which holds more stocks, XLV or RSPH?
XLV is broader, with 65 positions versus 63 for RSPH. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.